| http://www.w3.org/ns/prov#value | - Key personnel, including investigators and physicians from the hospitals involved in the clinical trials of Kevetrin???, Cellceutix's flagship anti-cancer compound being hosted at Harvard's Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, assisted in preparing the abstract.
|
